Sanofi (LON:0O59)

Market Cap	82.91B -20.5%
Revenue (ttm)	40.75B +5.5%
Net Income	6.82B +40.5%
EPS	5.58 +44.2%
Shares Out	n/a
PE Ratio	12.16
Forward PE	9.46
Dividend	3.30 (4.17%)
Ex-Dividend Date	May 12, 2025

Volume	1,480,371
Average Volume	849,982
Open	77.08
Previous Close	77.08
Day's Range	76.90 - 79.44
52-Week Range	76.22 - 110.84
Beta	0.40
RSI	43.89
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O59

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR